MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Changing Lifestyles for Better Health

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Behavioral: Intensive Lifestyle Intervention
First Posted Date
2009-02-20
Last Posted Date
2022-05-04
Lead Sponsor
Yale University
Target Recruit Count
130
Registration Number
NCT00848757
Locations
🇺🇸

Fair Haven Community Health Center, New Haven, Connecticut, United States

Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity

Phase 4
Terminated
Conditions
Pediatric Obesity
Insulin Resistance
Impaired Glucose Tolerance
Cardiovascular Disease
Interventions
First Posted Date
2009-02-18
Last Posted Date
2013-05-01
Lead Sponsor
Yale University
Target Recruit Count
23
Registration Number
NCT00846521
Locations
🇺🇸

Yale School of Medicine, New Haven, Connecticut, United States

The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults

Phase 4
Withdrawn
Conditions
Obesity
Cardiovascular Disease
Insulin Resistance
Impaired Glucose Tolerance
Interventions
First Posted Date
2009-02-18
Last Posted Date
2012-12-11
Lead Sponsor
Yale University
Registration Number
NCT00845559

Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma

Phase 2
Completed
Conditions
Hepatocellular Carcinoma
Hepatoma
Interventions
Procedure: LC Bead-TACE
First Posted Date
2009-02-16
Last Posted Date
2021-11-11
Lead Sponsor
Yale University
Target Recruit Count
50
Registration Number
NCT00844883
Locations
🇺🇸

The Johns Hopkins Hospital, Baltimore, Maryland, United States

Racial Differences in Orthostatic Tolerance

Completed
Conditions
Orthostatic Tolerance
First Posted Date
2009-02-16
Last Posted Date
2009-02-16
Lead Sponsor
Yale University
Target Recruit Count
18
Registration Number
NCT00844181
Locations
🇺🇸

John B. Pierce Laboratory, New Haven, Connecticut, United States

Dronabinol Interactions With Cognitive Enhancing Drug in Humans

Early Phase 1
Completed
Conditions
Cannabis
Marijuana Abuse
Interventions
Drug: drug condition
First Posted Date
2009-02-12
Last Posted Date
2017-05-30
Lead Sponsor
Yale University
Target Recruit Count
53
Registration Number
NCT00842985
Locations
🇺🇸

Department of Veterans Affairs Hospital, West Haven, Connecticut, United States

Transitions: Linkages From Jail To Community

Not Applicable
Completed
Conditions
HIV Infections
Substance Abuse
HIV
Interventions
Behavioral: Intensive Case Management
First Posted Date
2009-02-11
Last Posted Date
2016-08-12
Lead Sponsor
Yale University
Target Recruit Count
127
Registration Number
NCT00841711
Locations
🇺🇸

Waterbury Hosp ID Clinic, Waterbury, Connecticut, United States

🇺🇸

Yale Clinical Research, New Haven, Connecticut, United States

Pharmacotherapy & CM for Opioid and Cocaine Dependence

Phase 1
Completed
Conditions
Cocaine Dependence
Interventions
Drug: Sugar Pill
Behavioral: Contingency Management
Behavioral: cognitive behavioral treatment
Behavioral: Voucher Control
First Posted Date
2009-02-09
Last Posted Date
2021-12-03
Lead Sponsor
Yale University
Target Recruit Count
91
Registration Number
NCT00838981
Locations
🇺🇸

Department of Veterans Affairs, West Haven, Connecticut, United States

Positive Lifestyles Using Safety

Not Applicable
Completed
Conditions
HIV
HIV Infections
Interventions
Behavioral: Post-release (Group 2)
Behavioral: Pre-Release (Group 1)
First Posted Date
2009-02-04
Last Posted Date
2015-10-21
Lead Sponsor
Yale University
Target Recruit Count
90
Registration Number
NCT00836290
Locations
🇺🇸

Yale AIDS Program, Yale University School of Medicine, New Haven, Connecticut, United States

Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care

Not Applicable
Completed
Conditions
Binge Eating
Obesity
Interventions
Behavioral: Behavioral Weight Loss
Behavioral: Behavioral Weight Loss + Guided self-help Cognitive-behavioral Therapy
Drug: Placebo
Drug: Sibutramine/Orlistat
First Posted Date
2009-01-27
Last Posted Date
2020-04-03
Lead Sponsor
Yale University
Target Recruit Count
191
Registration Number
NCT00829283
Locations
🇺🇸

Yale School of Medicine, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath